This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hayward, D. G. Articles by Fry, A. M. Search for Related Content PubMed PubMed Citation Articles by Hayward, D. G. Articles by Fry, A. M.

The Centrosomal Kinase Nek2 Displays Elevated Levels of Protein Expression in Human Breast Cancer

¹ Department of Biochemistry, University of Leicester, Leicester; and ² Paterson Institute for Cancer Research, Manchester, United Kingdom

Aneuploidy and chromosome instability are common abnormalities in human cancer. Loss of control over mitotic progression, multipolar spindle formation, and cytokinesis defects are all likely to contribute to these phenotypes. Nek2 is a cell cycle-regulated protein kinase with maximal activity at the onset of mitosis that localizes to the centrosome. Functional studies have implicated Nek2 in regulation of centrosome separation and spindle formation. Here, we present the first study of the protein expression levels of the Nek2 kinase in human cancer cell lines and primary tumors. Nek2 protein is elevated 2- to 5-fold in cell lines derived from a range of human tumors including those of cervical, ovarian, breast, prostate, and leukemic origin. Most importantly, by immunohistochemistry, we find that Nek2 protein is significantly up-regulated in preinvasive in situ ductal carcinomas of the breast as well as in invasive breast carcinomas. Finally, by ectopic expression of Nek2A in immortalized HBL100 breast epithelial cells, we show that increased Nek2 protein leads to accumulation of multinucleated cells with supernumerary centrosomes. These data highlight the Nek2 kinase as novel potential target for chemotherapeutic intervention in breast cancer.

This article has been cited by other articles:

				J. L. Ordonez, D. Osuna, D. Herrero, E. de Alava, and J. Madoz-Gurpide Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead? Cancer Res., September 15, 2009; 69(18): 7140 - 7150. [Abstract] [Full Text] [PDF]

				G. Wu, X.-L. Qiu, L. Zhou, J. Zhu, R. Chamberlin, J. Lau, P.-L. Chen, and W.-H. Lee Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in Animal Cancer Res., October 15, 2008; 68(20): 8393 - 8399. [Abstract] [Full Text] [PDF]

				S. Bahmanyar, D. D. Kaplan, J. G. DeLuca, T. H. Giddings Jr., E. T. O'Toole, M. Winey, E. D. Salmon, P. J. Casey, W. J. Nelson, and A. I.M. Barth {beta}-Catenin is a Nek2 substrate involved in centrosome separation Genes & Dev., January 1, 2008; 22(1): 91 - 105. [Abstract] [Full Text] [PDF]

				T. Kokuryo, T. Senga, Y. Yokoyama, M. Nagino, Y. Nimura, and M. Hamaguchi Nek2 as an Effective Target for Inhibition of Tumorigenic Growth and Peritoneal Dissemination of Cholangiocarcinoma Cancer Res., October 15, 2007; 67(20): 9637 - 9642. [Abstract] [Full Text] [PDF]

				W. Wu, J. E. Baxter, S. L. Wattam, D. G. Hayward, M. Fardilha, A. Knebel, E. M. Ford, E. F. da Cruz e Silva, and A. M. Fry Alternative Splicing Controls Nuclear Translocation of the Cell Cycle-regulated Nek2 Kinase J. Biol. Chem., September 7, 2007; 282(36): 26431 - 26440. [Abstract] [Full Text] [PDF]

				I. Perez de Castro, G. de Carcer, and M. Malumbres A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy Carcinogenesis, May 1, 2007; 28(5): 899 - 912. [Abstract] [Full Text] [PDF]

				P. Rellos, F. J. Ivins, J. E. Baxter, A. Pike, T. J. Nott, D.-M. Parkinson, S. Das, S. Howell, O. Fedorov, Q. Y. Shen, et al. Structure and Regulation of the Human Nek2 Centrosomal Kinase J. Biol. Chem., March 2, 2007; 282(9): 6833 - 6842. [Abstract] [Full Text] [PDF]

				J. Mi, C. Guo, D. L. Brautigan, and J. M. Larner Protein Phosphatase-1{alpha} Regulates Centrosome Splitting through Nek2 Cancer Res., February 1, 2007; 67(3): 1082 - 1089. [Abstract] [Full Text] [PDF]

				P. A. Hall, C. B. Todd, P. L. Hyland, S. S. McDade, H. Grabsch, M. Dattani, K. J. Hillan, and S.E. H. Russell The Septin-Binding Protein Anillin Is Overexpressed in Diverse Human Tumors Clin. Cancer Res., October 1, 2005; 11(19): 6780 - 6786. [Abstract] [Full Text] [PDF]

				M. M. Fraser, P. M. Watson, M. M. Fraig, J. R. Kelley, P. S. Nelson, A. M. Boylan, D. J. Cole, and D. K. Watson CaSm-Mediated Cellular Transformation Is Associated with Altered Gene Expression and Messenger RNA Stability Cancer Res., July 15, 2005; 65(14): 6228 - 6236. [Abstract] [Full Text] [PDF]

				R. S. Hames, R. E. Crookes, K. R. Straatman, A. Merdes, M. J. Hayes, A. J. Faragher, and A. M. Fry Dynamic Recruitment of Nek2 Kinase to the Centrosome Involves Microtubules, PCM-1, and Localized Proteasomal Degradation Mol. Biol. Cell, April 1, 2005; 16(4): 1711 - 1724. [Abstract] [Full Text] [PDF]